1.Fritz MA, Speroff L. Clinical Gynecologyic Endocrinology and Infertility, 8th ed: Wolters Kluwer;2011. Vol 1. p.568-578.
2. Rayan Kenneth J. Kistner’s Gynecology. Translated by:Ghazi Jahani B, ghotbi R. Seventh edition. Tehran:printed by Golshan. Golban Publications;2008.P65
3- Forrester-Knauss C, Zemp Stutz E, Weiss C, Tschudin S. The interrelation between premenstrual syndrome and major depression: results from a population-based sample. BMC Public Health 2011 Oct; 12(11):795
4. Farokh-Eslamlou H, Nabilou B, Oshnoee S, Akbari E. The prevalence of premenstrual syndrome and its associated factors among medical students of urima university of medical science. URMIA MED J 2013: 24(9):702-710.
5. Ghare Khani P, Sadatyan S A.Cardinal manifestations & management of disease. Noordanesh Publications;2011. P 66.
6-
Direkvand Moghadam A,
Kaikhavani S,
Sayehmiri K. The Worldwide Prevalence of Premenstrual Syndrome: A Systematic Review and Meta-Analysis Study. The Iranian journal of obstetrics, Gynecology and Infertility. 2013 sep;16(65): 8 - 17.
7- Qiao M, Zhang H, Liu H, Luo S, Wang T, Zhang J, et al. Prevalence of premenstrual syndrome and premenstrual dysphoric disorder in a population-based sample in China. Eur J Obstet Gynecol Reprod Biol. 2012 May;162(1):83-6.
8- Ramezani Tehrani F, Hashemi S, Robab Allameh M. Prevalence of premenstrual syndrome and some of its relative factors in reproductive age. Horizon Med Sci . 2012; 18 (3) :121-127
9- Salehi A, Momeni H, Seraji A. Comparison of the effects of Hypericum and Vitex agnus premenstrual syndrome compared with vitamin E: a randomized clinical trial. Complementary Medicine Journal of faculty of Nursing & Midwifery 2013;3(1): 395 – 405.
10.Berek Jonathan S. Berek & Novak’s Gynecology1. 15th . Wolters Kluwer. 2012.Vol 1.P:311-314.
11.https://www.acog.org/-/media/For Patients/faq057. pdf?dmc=1&ts=20150125T0115384 73
12. Jean-Jacques D, Dugald S, Daniel P, Gideon K, Edward M. Safety and efficacy of chastetree (vitex agnus-castus) during pregnancy and lactation. The
Canadian Journal of Clinical Pharmacolog. 2008 winter;15(1):e74-9.
13. Jarry H, et al . evidence for estrogen receptor beta _ selective activity of vitex agnus _ castus and Isolated flavones ._ planta Med . 2003 Oct ; 69 (10) p :945 _ 7.
14.Sakhavat L, Zare Tzrjany F, Kholasezade P. The effect of herbal .Vitagnus on
women's Mastalgia. Southern Medical Journal.. 2008 March; 11(2): 147-52.
15. schellenberg R. “Treatment for premenstrual syndrome with agnus castus Fruit extract: prospective,. randomized , placebo controlled study .” BMJ 2001 ; 322: 134 _137.
17. Turner S . Mills S . “A double _ blind clinical trial on a herbal remedy for premenstrual syndrome : a case study .” complementary therapies in medicine 1993 . 1. P :73 _77
19. Salami MR, Safarnejad A,Hamidi H. The effect of salinity on morphologic characteristics cumin and valerian. Research and Development Journal. 2006; 72:77-83[Persian].
20. Mortola J . F . and et al . “Diagnosis of premenstrual syndrome by a simple prospective and Reliable Instrument : The calendar of premenstrual Experiences .” Obstet Gynecol : Augst 1990 . Vol 76 . .p: 302 _ 307
23.Donald J. Brown, ND. Herbal Extract Alleviates PMS Symptoms.
https://www.thebetterhealthstore.com/News/PMS012501.html
24. .Atmaca M, kumru S, Tezcon E."Fluoxetine Versus vitex agnus castus extract in the treatment of premenstrual dysphoric disorder." Hum psychopharmacol. 2003 Apr;18(3):191 _5.
25. Berger D , et al . Eifficacy of vitex agnus castus L.extract Ze 440 in patients with pre - menstrual syndrome (PMS) .Arch Gynecol obstet 2000 . 264 ; p : 150 -153.